☰

Richard A. Luben - Publications

Affiliations: 
University of California, Riverside, Riverside, CA, United States 
Area:
Biochemistry, Molecular Biology
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Tan D, Chen KE, Deng C, Tang P, Huang J, Mansour T, Luben RA, Walker AM. An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma. Cancer Letters. 346: 148-57. PMID 24384092 DOI: 10.1016/J.Canlet.2013.12.030  0.647
2009 Deng C, Ueda E, Chen KE, Bula C, Norman AW, Luben RA, Walker AM. Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Molecular Endocrinology (Baltimore, Md.). 23: 226-36. PMID 19074549 DOI: 10.1210/Me.2008-0075  0.652
2001 Lindström E, Still M, Mattsson MO, Mild KH, Luben RA. ELF magnetic fields initiate protein tyrosine phosphorylation of the T cell receptor complex. Bioelectrochemistry (Amsterdam, Netherlands). 53: 73-8. PMID 11206927 DOI: 10.1016/S0302-4598(00)00125-2  0.359
2000 Coss D, Yang L, Kuo CB, Xu X, Luben RA, Walker AM. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat American Journal of Physiology - Endocrinology and Metabolism. 279: E1216-E1225. PMID 11093907 DOI: 10.1152/Ajpendo.2000.279.6.E1216  0.682
1999 Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM. Dissociation of Janus Kinase 2 and Signal Transducer and Activator of Transcription 5 Activation after Treatment of Nb2 Cells with a Molecular Mimic of Phosphorylated Prolactin1. Endocrinology. 140: 5087-5094. PMID 28200725 DOI: 10.1210/endo.140.11.7104  0.68
1999 Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin Endocrinology. 140: 5087-5094. PMID 10537136 DOI: 10.1210/Endo.140.11.7104  0.696
1995 Uckun FM, Kurosaki T, Jin J, Jun X, Morgan A, Takata M, Bolen J, Luben R. Exposure of B-lineage lymphoid cells to low energy electromagnetic fields stimulates Lyn kinase. The Journal of Biological Chemistry. 270: 27666-70. PMID 7499232 DOI: 10.1074/Jbc.270.46.27666  0.38
1991 Nemere I, Leathers VL, Thompson BS, Luben RA, Norman AW. Redistribution of calbindin-D28k in chick intestine in response to calcium transport. Endocrinology. 129: 2972-84. PMID 1659521 DOI: 10.1210/Endo-129-6-2972  0.3
1987 Cain CD, Adey WR, Luben RA. Evidence that pulsed electromagnetic fields inhibit coupling of adenylate cyclase by parathyroid hormone in bone cells. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 2: 437-41. PMID 3455626 DOI: 10.1002/Jbmr.5650020511  0.39
1985 Weinshank RL, Luben RA. Identification of a 150-kDa membrane component which is modulated by parathyroid hormone. European Journal of Biochemistry / Febs. 153: 179-88. PMID 2998791 DOI: 10.1111/J.1432-1033.1985.Tb09284.X  0.36
1985 Weinshank RL, Cain CD, Vasquez NP, Luben RA. Identification of a monoclonal antibody which interacts with the parathyroid hormone receptor-adenylate cyclase system in murine bone. Molecular and Cellular Endocrinology. 41: 237-46. PMID 2991044 DOI: 10.1016/0303-7207(85)90028-0  0.368
1984 Griffin FM, Luben RA, Golde DW. A human lymphokine activates macrophage C3 receptors for phagocytosis: studies using monoclonal anti-lymphokine antibodies. Journal of Leukocyte Biology. 36: 95-109. PMID 6379083 DOI: 10.1002/Jlb.36.2.95  0.313
1984 Nedwin GE, Mohler MA, Luben RA. Production of human/mouse hybridomas secreting a human lymphokine, osteoclast activating factor. Cellular Immunology. 84: 324-32. PMID 6368007 DOI: 10.1016/0008-8749(84)90104-7  0.379
1983 Rosen DM, Luben RA. Multiple hormonal mechanisms for the control of collagen synthesis in an osteoblast-like cell line, MMB-1. Endocrinology. 112: 992-9. PMID 6337052 DOI: 10.1210/Endo-112-3-992  0.402
1983 Wehrenberg WB, Brazeau P, Luben R, Ling N, Guillemin R. A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor. Neuroendocrinology. 36: 489-91. PMID 6136006 DOI: 10.1159/000123504  0.317
1982 Luben RA, Brazeau P, Böhlen P, Guillemin R. Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen. Science (New York, N.Y.). 218: 887-9. PMID 6813967 DOI: 10.1126/Science.6813967  0.307
1982 Wehrenberg WB, Brazeau P, Luben R, Böhlen P, Guillemin R. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology. 111: 2147-8. PMID 6128220 DOI: 10.1210/Endo-111-6-2147  0.32
1980 Luben RA. An assay for osteoclast-activating factor (OAF) in biological fluids: detection of OAF in the serum of myeloma patients. Cellular Immunology. 49: 74-80. PMID 7351032 DOI: 10.1016/0008-8749(80)90057-X  0.348
1980 Luben RA, Mohler MA. In vitro immunization as an adjunct to the production of hybridomas producing antibodies against the lymphokine osteoclast activating factor. Molecular Immunology. 17: 635-9. PMID 7194419 DOI: 10.1016/0161-5890(80)90161-3  0.307
1979 Luben RA, Chen MC, Rosen DM, Mohler MA. Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells. Calcified Tissue International. 28: 23-32. PMID 227549 DOI: 10.1007/Bf02441214  0.377
1979 Luben RA, Mohler MA, Nedwin GE. Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor. The Journal of Clinical Investigation. 64: 337-41. PMID 221547 DOI: 10.1172/Jci109459  0.327
1978 Luben RA. Purification of a lymphokine: osteoclast activating factor from human tonsil lymphocytes. Biochemical and Biophysical Research Communications. 84: 15-22. PMID 728122 DOI: 10.1016/0006-291X(78)90256-5  0.363
1977 Wong GL, Luben RA, Cohn DV. 1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. Science (New York, N.Y.). 197: 663-5. PMID 195343 DOI: 10.1126/Science.195343  0.406
1976 Luben RA, Cohn DV. Effects of parathormone and calcitonin on citrate and hyaluronate metabolism in cultured bone. Endocrinology. 98: 413-9. PMID 942914 DOI: 10.1210/Endo-98-2-413  0.319
1976 Luben RA, Wong GL, Cohn DV. Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology. 99: 526-34. PMID 182458 DOI: 10.1210/Endo-99-2-526  0.351
1975 Raisz LG, Luben RA, Mundy GR, Dietrich JW, Horton JE, Trummel CL. Effect of osteoclast activating factor from human leukocytes on bone metabolism Journal of Clinical Investigation. 56: 408-413. PMID 1171115 DOI: 10.1172/Jci108106  0.388
1974 Luben RA, Mundy GR, Trummel CL, Raisz LG. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes. The Journal of Clinical Investigation. 53: 1473-80. PMID 4825237 DOI: 10.1172/Jci107696  0.378
1974 Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN. Bone-resorbing activity in supernatants from lymphoid cell lines. The New England Journal of Medicine. 290: 867-71. PMID 4816960 DOI: 10.1056/Nejm197404182901601  0.376
1974 Luben RA, Goggins JF, Raisz LG. Stimulation by parathyroid hormone of bone hyaluronate synthesis in organ culture. Endocrinology. 94: 737-45. PMID 4813676 DOI: 10.1210/Endo-94-3-737  0.35
Show low-probability matches.